Please use this identifier to cite or link to this item: http://sgc.anlis.gob.ar/handle/123456789/896
Title: Germline pathogenic variants in BRCA1, BRCA2, PALB2 and RAD51C in breast cancer women from Argentina
Authors: Cerretini, Roxana 
Mercado, Graciela 
Morganstein, Josh 
Schiaffi, Jorge 
Reynoso, Mónica 
Montoya, Diana 
Valdez, Rita 
Narod, Steven A 
Akbari, Mohammad R 
Keywords: Argentina;Neoplasias de la Mama;Mutación;Proteína del Grupo de Complementación N de la Anemia de Fanconi
Issue Date: 24-Aug-2019
Journal: Breast cancer research and treatment 
Abstract: 
Each year, 17,000 new breast cancer cases are diagnosed in Argentina, and 5400 women die of breast cancer. The contribution of cancer-related mutations to the incidence of breast cancer in Argentina has not yet been explored.
Description: 
Fil: Cerretini, R. ANLIS Dr.C.G.Malbrán. Centro Nacional de Genética Médica Dr. Eduardo Castilla; Argentina.

Fil: Mercado, G. ANLIS Dr.C.G.Malbrán. Centro Nacional de Genética Médica Dr. Eduardo Castilla; Argentina.

Fil: Morganstein, Josh. Women’s College Research InstituteWomen’s College Hospital; Canada

Fil: Schiaffi, Jorge. Sección de Patología Mamaria. Servicio de Ginecología Hospital Bernardino Rivadavia; Buenos Aires; Argentina

Fil: Reynoso, M. Servicio de Ginecología. Hospital Evita de Lanús; Buenos Aires; Argentina

Fil: Montoya, D. Servicio de Patología Mamaria. Instituto de Oncología Dr. Angel H Roffo; Buenos Aires; Argentina

Fil: Valdez, R. Servicio de Genética. Hospital Militar Central; Buenos Aires; Argentina

Fil: Narod, SA. Dalla Lana School of Public Health. University of Toronto; Toronto; Canadá

Fil: Akbari, MR. Women’s College Research Institute. Women’s College Hospital; Canada
URI: http://sgc.anlis.gob.ar/handle/123456789/896
DOI: 10.1007/s10549-019-05411-9
Appears in Collections:Publicaciones CeNaGeM

Show full item record

Visualização de página

216
Checado em 06/04/2026

Google ScholarTM

Checar

Altmetric

Altmetric


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.